Health takes cen­ter stage at an­nu­al CES tech bash with ad­vanced wear­ables, tele­health deals and lat­est in Covid test­ing

From biowear­ables to smart at-home health care and mon­i­tor­ing, health tech­nol­o­gy took cen­ter­stage at CES last week. Lit­er­al­ly, in fact, with Ab­bott pre­sent­ing the first-ever health­care keynote at the an­nu­al sem­i­nal tech fest.

Ab­bott, which makes FreeStyle Li­bre blood glu­cose mon­i­tors, took the spot­light op­por­tu­ni­ty to an­nounce its move in­to con­sumer biowear­ables. Its new­ly un­veiled line of Lin­go prod­ucts will track and mea­sure not on­ly glu­cose, but al­so lac­tate and ke­tones and even­tu­al­ly al­co­hol lev­els. Build­ing on its glu­cose tech, the fu­ture prod­ucts cen­ter on a sim­i­lar cir­cu­lar wear­able patch that con­stant­ly mon­i­tors meta­bol­ic blood mark­ers and re­ports re­sults through a smart­phone app.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER